Head to Head

CMCO vs UROY: which is the better buy in 2026?

Columbus McKinnon Corporation

NASDAQ:CMCO

82/100 Compass
True NorthAccumulate$596M

Post-Kito integration mess creates 0.68x book entry into a 150-year-old motion business trading like it's going out of business.

Full CMCO analysis

Uranium Royalty Corp.

NASDAQ:UROY

82/100 Compass
True NorthAccumulate$540M

The only pure-play uranium royalty vehicle, levered to a price cycle that's still in its early innings with zero capex drag.

Full UROY analysis

Factor by factor

FactorCMCOUROY
Revenue Growth9898
Profitability2437
Valuation8143
Momentum6839
Theme Purity5462
Moat4745
Catalysts5772
Market Position5250

Get head-to-heads like this, free

Join the Alexandria e-letter for Compass verdicts, earnings intelligence, and the contrarian calls the crowd misses. Twice a week, no noise.

Free forever. Unsubscribe anytime. We never share your email.

Frequently asked questions

Is CMCO or UROY the better buy in 2026?

CMCO and UROY are neck and neck at 82/100 on the Compass right now. The better fit depends on which factors matter most to you.

How does Alexandria compare CMCO and UROY?

Each company is scored 1-100 on eight factors: revenue growth, profitability, valuation, momentum, theme purity, moat, catalysts, and market position. The Compass Score is the composite, and the comparison below shows where each name wins factor by factor.

Compass Scores are proprietary editorial research from publicly available data, not investment advice or a recommendation regarding any security. Rankings update weekly.